Pdt Partners, LLC Merrimack Pharmaceuticals Inc Transaction History

Pdt Partners, LLC

  • $1.02 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018
SELL
$3.91 - $4.66 $113,390 - $135,140
-29,000 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$3.86 - $7.61 $93,026 - $183,401
-24,100 Reduced 45.39%
29,000 $142,000
Q1 2018

May 15, 2018
SELL
$6.24 - $9.15 $30,600 - $44,871
-4,904 Reduced 8.45%
53,100 $427,000
Q4 2017

Feb 14, 2018
BUY
$7.99 - $11.87 $463,451 - $688,507
58,004
58,004 $595,000

Others Institutions Holding MACK

# of Institutions
2
Shares Held
349
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email